These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 24889123)

  • 1. Senescence of bone marrow mesenchymal stromal cells is accompanied by activation of p53/p21 pathway in myelodysplastic syndromes.
    Fei C; Zhao Y; Guo J; Gu S; Li X; Chang C
    Eur J Haematol; 2014 Dec; 93(6):476-86. PubMed ID: 24889123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of Dicer1 promotes cellular senescence and decreases the differentiation and stem cell-supporting capacities of mesenchymal stromal cells in patients with myelodysplastic syndrome.
    Zhao Y; Wu D; Fei C; Guo J; Gu S; Zhu Y; Xu F; Zhang Z; Wu L; Li X; Chang C
    Haematologica; 2015 Feb; 100(2):194-204. PubMed ID: 25361944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Notch-Hes pathway mediates the impaired osteogenic differentiation of bone marrow mesenchymal stromal cells from myelodysplastic syndromes patients through the down-regulation of Runx2.
    Fei C; Guo J; Zhao Y; Gu S; Zhao S; Li X; Chang C
    Am J Transl Res; 2015; 7(10):1939-51. PubMed ID: 26692937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-29c-3p promotes senescence of human mesenchymal stem cells by targeting CNOT6 through p53-p21 and p16-pRB pathways.
    Shang J; Yao Y; Fan X; Shangguan L; Li J; Liu H; Zhou Y
    Biochim Biophys Acta; 2016 Apr; 1863(4):520-32. PubMed ID: 26792405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular senescence induced by S100A9 in mesenchymal stromal cells through NLRP3 inflammasome activation.
    Shi L; Zhao Y; Fei C; Guo J; Jia Y; Wu D; Wu L; Chang C
    Aging (Albany NY); 2019 Nov; 11(21):9626-9642. PubMed ID: 31727865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53/p21 Pathway involved in mediating cellular senescence of bone marrow-derived mesenchymal stem cells from systemic lupus erythematosus patients.
    Gu Z; Jiang J; Tan W; Xia Y; Cao H; Meng Y; Da Z; Liu H; Cheng C
    Clin Dev Immunol; 2013; 2013():134243. PubMed ID: 24151513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of p53-p21 pathway promotes the differentiation of rat bone marrow mesenchymal stem cells into cardiomyocytes.
    Yan X; Lv A; Xing Y; Liu B; Hou J; Huang W; Li Y
    Mol Cell Biochem; 2011 Aug; 354(1-2):21-8. PubMed ID: 21468649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inappropriate Notch activity and limited mesenchymal stem cell plasticity in the bone marrow of patients with myelodysplastic syndromes.
    Varga G; Kiss J; Várkonyi J; Vas V; Farkas P; Pálóczi K; Uher F
    Pathol Oncol Res; 2007; 13(4):311-9. PubMed ID: 18158566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor β1-mediated functional inhibition of mesenchymal stromal cells in myelodysplastic syndromes and acute myeloid leukemia.
    Geyh S; Rodríguez-Paredes M; Jäger P; Koch A; Bormann F; Gutekunst J; Zilkens C; Germing U; Kobbe G; Lyko F; Haas R; Schroeder T
    Haematologica; 2018 Sep; 103(9):1462-1471. PubMed ID: 29773599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dicer1 downregulation by multiple myeloma cells promotes the senescence and tumor-supporting capacity and decreases the differentiation potential of mesenchymal stem cells.
    Guo J; Zhao Y; Fei C; Zhao S; Zheng Q; Su J; Wu D; Li X; Chang C
    Cell Death Dis; 2018 May; 9(5):512. PubMed ID: 29724992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Replicative senescence of human bone marrow and umbilical cord derived mesenchymal stem cells and their differentiation to adipocytes and osteoblasts.
    Cheng H; Qiu L; Ma J; Zhang H; Cheng M; Li W; Zhao X; Liu K
    Mol Biol Rep; 2011 Nov; 38(8):5161-8. PubMed ID: 21188535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD34+ cells from patients with myelodysplastic syndrome present different p21 dependent premature senescence.
    Xiao Y; Wang J; Song H; Zou P; Zhou D; Liu L
    Leuk Res; 2013 Mar; 37(3):333-40. PubMed ID: 23219618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insufficient stromal support in MDS results from molecular and functional deficits of mesenchymal stromal cells.
    Geyh S; Oz S; Cadeddu RP; Fröbel J; Brückner B; Kündgen A; Fenk R; Bruns I; Zilkens C; Hermsen D; Gattermann N; Kobbe G; Germing U; Lyko F; Haas R; Schroeder T
    Leukemia; 2013 Sep; 27(9):1841-51. PubMed ID: 23797473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wnt/β-catenin signaling mediates the senescence of bone marrow-mesenchymal stem cells from systemic lupus erythematosus patients through the p53/p21 pathway.
    Gu Z; Tan W; Feng G; Meng Y; Shen B; Liu H; Cheng C
    Mol Cell Biochem; 2014 Feb; 387(1-2):27-37. PubMed ID: 24130040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired proliferative potential of bone marrow mesenchymal stromal cells in patients with myelodysplastic syndromes is associated with abnormal WNT signaling pathway.
    Pavlaki K; Pontikoglou CG; Demetriadou A; Batsali AK; Damianaki A; Simantirakis E; Kontakis M; Galanopoulos A; Kotsianidis I; Kastrinaki MC; Papadaki HA
    Stem Cells Dev; 2014 Jul; 23(14):1568-81. PubMed ID: 24617415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The bone marrow stem stromal imbalance--a key feature of disease progression in case of myelodysplastic mouse model.
    Das M; Chatterjee S; Basak P; Das P; Pereira JA; Dutta RK; Chaklader M; Chaudhuri S; Law S
    J Stem Cells; 2010; 5(2):49-64. PubMed ID: 22049615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Senescence-Associated Secretory Phenotype of Bone Marrow Mesenchymal Stem Cells Inhibits the Viability of Breast Cancer Cells.
    Li M; Liu JX; Ma B; Liu JY; Chen J; Jin F; Hu CH; Xu HK; Zheng CX; Hou R
    Stem Cell Rev Rep; 2024 May; 20(4):1093-1105. PubMed ID: 38457059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aging- and Senescence-associated Changes of Mesenchymal Stromal Cells in Myelodysplastic Syndromes.
    Mattiucci D; Maurizi G; Leoni P; Poloni A
    Cell Transplant; 2018 May; 27(5):754-764. PubMed ID: 29682980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydrogen alleviates cellular senescence via regulation of ROS/p53/p21 pathway in bone marrow-derived mesenchymal stem cells in vivo.
    Zhang W; Huang C; Sun A; Qiao L; Zhang X; Huang J; Sun X; Yang X; Sun S
    Biomed Pharmacother; 2018 Oct; 106():1126-1134. PubMed ID: 30119179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional characteristics of mesenchymal stem cells derived from bone marrow of patients with myelodysplastic syndromes.
    Zhao ZG; Xu W; Yu HP; Fang BL; Wu SH; Li F; Li WM; Li QB; Chen ZC; Zou P
    Cancer Lett; 2012 Apr; 317(2):136-43. PubMed ID: 22240014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.